Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America by Weber Donna M, Chen Christine, Niesvizky Ruben, Wang Michael, Belch Andrew, Stadtmauer Edward A, Siegel David, Borrello Ivan, Rajkumar S Vincent, Chanan-Khan Asher Alban, Lonial Sagar, Yu Zhinuan, Patin John, Olesnyckyj Marta, Zeldis Jerome B, Knight Robert D, Multiple Myeloma (009) Study Investigators in The New England journal of medicine (2007). PubMed


Lenalidomide, an oral immunomodulatory drug that is similar to thalidomide but has a different safety profile, has clinical activity in relapsed or refractory multiple myeloma.

[ hide abstract ]

Discussed In Paper


Dosing Information

No dosing information annotated.